The gastrointestinal stability of lipid nanocapsules

  • Roger E
  • Lagarce F
  • Benoit J
  • 79

    Readers

    Mendeley users who have this article in their library.
  • 55

    Citations

    Citations of this article.

Abstract

The in vitro gastrointestinal stability of lipid nanocapsules (LNCs) was studied in different media. The size of LNCs was determined in simulated gastric and intestinal media. In updated fasted state simulated intestinal fluid (FaSSIF-V2) and updated fed state simulated intestinal fluid (FeSSIF-V2) media, the encapsulation ratio of paclitaxel-loaded LNCs was also measured. The size of LNCs was not modified after 3 h in simulated gastric fluid and simulated intestinal fluid described by the United States Pharmacopeia, in FaSSIF, FaSSIF-V2, and in FeSSIF. Moreover, in the presence of pancreatin in FeSSIF-V2, a decreased above 30% of the loading of paclitaxel was observed. This was attributed to the presence of lipase in pancreatin that could interact with Lipoid?? (a mixture of phosphatidylcholine and phosphatidylethanolamine), present on the shell of LNC. As a conclusion, LNCs were stable on gastric medium and fasted state intestinal medium. ?? 2009 Elsevier B.V. All rights reserved.

Author-supplied keywords

  • Gastrointestinal tract
  • Lipid nanocapsules
  • Paclitaxel
  • Simulated media
  • Stability

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • E. Roger

  • F. Lagarce

  • J. P. Benoit

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free